Skip to main content
Clinical Trials/NCT03010813
NCT03010813CompletedNot Applicable

A Novel Robotic System for Single Port and Natural Orifice Transluminal Endoscopic Surgery: A Prospective, Single Center, Multispecialty Study

Chinese University of Hong Kong1 site in 1 country63 target enrollmentStarted: December 1, 2016Last updated:
Conditions
Interventions

Trial Snapshot

Phase
Not Applicable
Status
Completed
Enrollment
63
Locations
1
Primary Endpoint
Conversion rate

Study Overview

Brief Summary

This is a prospective, single center, multispecialty study that aimed to evaluate the clinical feasibility and safety of single port surgery and NOTES (mainly transanal and transoral surgery) using a novel single port robotic system.

Detailed Description

Background: Single port surgery and natural orifice transluminal endoscopic surgery (NOTES) are emerging minimally invasive surgery techniques which can further reduce patient trauma and enhance recovery. However, the wider adoption of these techniques is hampered by the limitation of instrumentation and technical difficulties. Robotic assistance may improve surgical capabilities during single port surgery and NOTES by providing augmented motion precision and manipulation dexterity.

Objectives: To evaluate the clinical feasibility and safety of single port surgery and NOTES (mainly transanal and transoral surgery) using a novel single port robotic system.

Design: Prospective, single center, multispecialty study consistent with a stage 1 (Innovation) study described in the Innovation, Development, Exploration, Assessment, Long-term Study (IDEAL) framework.

Subjects: Sixty consecutive patients with various benign/malignant pathologies indicated for single port colorectal/urologic surgery or transanal/transoral surgery who fulfilled all the inclusion and exclusion criteria will be recruited.

Intervention: Single port surgery and transanal/transoral surgery will be performed using the novel single port robotic system.

Study Design

Study Type
Interventional
Allocation
Na
Intervention Model
Single Group
Primary Purpose
Treatment
Masking
None

Eligibility Criteria

Ages
18 Years to — (Adult, Older Adult)
Sex
All
Accepts Healthy Volunteers
No

Inclusion Criteria

  • •GENERAL INCLUSION CRITERIA FOR ALL PROCEDURES
  • •Body mass index <35 kg/m2
  • •Suitable for minimally invasive surgery
  • •Willingness to participate as demonstrated by giving informed consent

Exclusion Criteria

  • •FOR ALL PROCEDURES
  • •Contraindication to general anesthesia
  • •Severe concomitant illness that drastically shortens life expectancy or increases risk of therapeutic intervention
  • •Untreated active infection
  • •Noncorrectable coagulopathy
  • •Presence of another malignancy or distant metastasis
  • •Emergency surgery
  • •Vulnerable population (e.g. mentally disabled, pregnancy)

Arms & Interventions

Novel single port robotic system

Experimental

A single port innovation designed to deliver an articulating 3D high definition camera and three fully articulating instruments through a single 25-mm cannula

Intervention: Robotic single port surgery and NOTES (Procedure)

Outcomes

Primary Outcomes

Conversion rate

Time Frame: Up to 1 month

An emergent change in the treatment plan to conventional minimally invasive (laparoscopic/endoscopic) surgery (i.e. the use of more than one additional port), multiport robotic surgery, or to open surgery

Perioperative complications

Time Frame: Up to 1 month

Complications including intraoperative complications and all complications occurring during the hospital stay or within 30 days after discharge will be graded according to the Clavien-Dindo classification

Secondary Outcomes

  • Completeness of resection(Up to 1 month)
  • Resection margins(Up to 1 month)
  • Number of lymph nodes harvested(Up to 1 month)
  • Anal continence after transanal surgery(Up to 1 year)
  • Fecal incontinence quality of life after transanal surgery(Up to 1 year)
  • Urinary continence after radical prostatectomy(Up to 1 year)
  • Male sexual function after radical prostatectomy(Up to 1 year)
  • Operative time(Intraoperative)
  • Estimated blood loss(Up to 1 month)
  • Renal function after nephrectomy(Up to 1 year)
  • Swallowing function after transoral robotic surgery (TORS)(Up to 1 year)
  • Voice function after TORS(Up to 1 year)
  • Pain scores on a visual analog scale(Up to 1 month)
  • Analgesic requirement(Up to 1 month)
  • Length of hospital stay(Up to 1 month)

Investigators

Sponsor Class
Other
Responsible Party
Principal Investigator
Principal Investigator

Simon S. M. Ng

Professor of Surgery

Chinese University of Hong Kong

Study Sites (1)

Loading locations...

Similar Trials